SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-231669
Filing Date
2023-09-08
Accepted
2023-09-08 17:19:54
Documents
12
Period of Report
2023-09-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d515463d8k.htm   iXBRL 8-K 45679
  Complete submission text file 0001193125-23-231669.txt   175053

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mgta-20230908.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20230908_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20230908_pre.xml EX-101.PRE 11711
6 EXTRACTED XBRL INSTANCE DOCUMENT d515463d8k_htm.xml XML 3514
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 231246169
SIC: 2834 Pharmaceutical Preparations